Atossa Therapeutics Applauds U.S. Surgeon General’s Advisory Highlighting Alcohol as a Leading Preventable Cause of Breast Cancer

Core Insights - Atossa Therapeutics supports the U.S. Surgeon General's Advisory linking alcohol consumption to increased breast cancer risk, emphasizing the need for public awareness and education on this issue [1][3][5] Industry Insights - Alcohol consumption is responsible for nearly 100,000 cancer cases and approximately 20,000 cancer deaths annually in the U.S., making it the third leading preventable cause of cancer after tobacco and obesity [2] - Breast cancer accounts for about 44,180 alcohol-related cases in women each year, representing approximately 16.4% of all breast cancer diagnoses [2] - The Advisory indicates that the risk of breast cancer begins to rise with the consumption of as little as one drink per day, yet only 45% of Americans believe alcohol significantly affects cancer development [3][4] Company Initiatives - Atossa Therapeutics is committed to advancing therapies aimed at reducing breast cancer burden and supports public policies that inform and protect women's health [5] - The company has released a video to further educate the public about the Surgeon General's Advisory and its implications for breast cancer [4] - Atossa advocates for updating health warning labels on alcoholic beverages, expanding public education efforts, and incorporating alcohol reduction strategies into cancer prevention initiatives [8]